Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 100 for soft tissue sarcoma

Edit search filters
  1. Analysis of Outcomes in Sarcoma Reconstruction Using Intraoperative Fluorescence Angiography

    Jacksonville, FL

  2. A Study of Sarcoma Tissue Collection

    Scottsdale/Phoenix, AZ

  3. Biomarkers in Sarcoma

    Rochester, MN

  4. Collection of Sarcoma Tissue Study

    Scottsdale/Phoenix, AZ

  5. Collection of Primary Retroperitoneal Sarcoma Data, Radiological, and Pathological Material for the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

    Jacksonville, FL

  6. Outcomes for Hand and Foot Soft Tissue Sarcomas Treated with Limb Sparing Multimodal Therapy

    Rochester, MN

  7. Advanced MR Imaging in Sarcoma Patients

    Rochester, MN

  8. Retrospective Review of Radiological Findings of Uterine Leiomyosarcoma in Comparison with Those of Atypical Leiomyoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Blood-Based Biomarkers in Sarcoma: A ‘Multi-Omics’ Approach

    Rochester, MN

  10. Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young

    Rochester, MN

.

Mayo Clinic Footer